Gender and the renal nitric oxide synthase system in healthy humans

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 5, 2007, Pages 916-931

  Ahmed, Sofia B ^a,c   Fisher, Naomi D L ^b   Hollenberg, Norman K ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; HUMAN; KIDNEY; KIDNEY CIRCULATION; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SEX DIFFERENCE;

ADULT; ENZYME INHIBITORS; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RENAL CIRCULATION; SEX FACTORS;

EID: 34548859001     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00110107     Document Type: Article

References (47)

1. Jungers P, Chauveau P, Descamps-Latscha B, Labrunie M, Giraud E, Man NK, Grunfeld JP, Jacobs C: Age and gender-related incidence of chronic renal failure in a French urban area: A prospective epidemiologic study. Nephrol Dial Transplant 11: 1542-1546, 1996
2. Hannedouche T, Chauveau P, Kalou F, Albouze G, Lacour B, Jungers P: Factors affecting progression in advanced chronic renal failure. Clin Nephrol 39: 312-320, 1993
3. Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving HH: Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: Inception cohort study. BMJ 328: 1105, 2004
4. Rekola S, Bergstrand A, Bucht H: Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance. Kidney Int 40: 1050-1054, 1991
5. Macias-Nunez JF, Stewart CJ: Renal function in the elderly. In: Oxford Textbook of Clinical Nephrology, edited by Grunfeld JP, Ponticelli C, van Ypersal C, Davison A, Cameron S, Oxford, Oxford University Press, 1992, pp 56-70
6. Wesson LG: Renal hemodynamics in physiological states. In: Physiology of the Human Kidney, New York, Grune and Stratton, 1969, pp 96-108
7. Kielstein JT, Bode-Boger SM, Frolich JC, Ritz E, Haller H, Fliser D: Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 107: 1891-1895, 2003
8. Reckelhoff JF, Hennington BS, Moore AG, Blanchard EJ, Cameron J: Gender differences in the renal nitric oxide (NO) system: Dissociation between expression of endothelial NO synthase and renal hemodynamic response to NO synthase inhibition. Am J Hypertens 11: 97-104, 1998
9. Moroi M, Zhang L, Yasuda T, Virmani R, Gold HK, Fishman MC, Huang PL: Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest 101: 1225-1232, 1998
10. Wangensteen R, Moreno JM, Sainz J, Rodriguez-Gomez I, Chamorro V, Luna Jde D, Osuna A, Vargas F: Gender difference in the role of endothelium-derived relaxing factors modulating renal vascular reactivity. Eur J Pharmacol 486: 281-288, 2004
11. Yoshida I, Bengal R, Torres VE: Gender-dependent effect of L-NAME on polycystic kidney disease in Han:SPRD rats. Am J Kidney Dis 35: 930-936, 2000
12. Hill C, Lateef AM, Engels K, Samsell L, Baylis C: Basal and stimulated nitric oxide in control of kidney function in the aging rat. Am J Physiol 272: R1747-R1753, 1997
13. Reckelhoff JF, Kellum JA, Blanchard EJ, Bacon EE, Wesley AJ, Kruckeberg WC: Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging. Life Sci 55: 1895-1902, 1994
14. Sonaka I, Futami Y, Maki T: L-arginine-nitric oxide pathway and chronic nephropathy in aged rats. J Gerontol 49: B157-B161, 1994
15. Erdely A, Greenfeld Z, Wagner L, Baylis C: Sexual dimorphism in the aging kidney: Effects on injury and nitric oxide system. Kidney Int 63: 1021-1026, 2003
16. Forte P, Kneale BJ, Milne E, Chowienczyk PJ, Johnston A, Benjamin N, Ritter JM: Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension 32: 730-734, 1998
17. Shoback DM, Williams GH, Hollenberg NK, Davies RO, Moore TJ, Dluhy RG: Endogenous Ang II as a determinant of sodium modulated changes in tissue responsiveness to Ang II in normal man. J Clin Endocrinol Metab 57: 764-770, 1983
18. Grisham MB, Johnson GG, Lancaster JR Jr: Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol 268: 237-246, 1996
19. Ishii N, Ikenaga H, Carmines PK, Aoki Y, Ogawa Z, Saruta T, Suga T: High glucose augments arginase activity and nitric oxide production in the renal cortex. Metabolism 53: 868-874, 2004
20. Prabhakar SS: Role of nitric oxide in diabetic nephropathy. Semin Nephrol 24: 333-344, 2004
21. Engeli S, Janke J, Gorzelniak K, Bohnke J, Ghose N, Lindschau C, Luft FC, Sharma AM: Regulation of the nitric oxide system in human adipose tissue. J Lipid Res 45: 1640-1648, 2004
22. Baylis C: Nitric oxide deficiency; both consequence and cause of chronic renal disease (CRD). Hypertens Nephrol 5: 193-201, 2001
23. Zatz R, Baylis C: Chronic nitric oxide inhibition model six years on. Hypertension 32: 958-964, 1998
24. Kielstein JT, Boger RH, Bode-Boger SM, Frölich JC, Haller H, Ritz E, Fliser D: Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 13: 170-176, 2002
25. Fliser D, Kronenberg F, Kielstein JT, Morath C, Bode-Boger SM, Haller H, Ritz E: Asymmetric dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study. J Am Soc Nephrol 16: 2456-2461, 2005
26. Caglar K, Yilmaz MI, Sonmez A, Cakir E, Kaya A, Acikel C, Eyileten T, Yenicesu M, Oguz Y, Bilgi C, Oktenli C, Vural A, Zoccali C: ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease. Kidney Int 70: 781-787, 2006
27. Schulze F, Maas R, Freese R, Schwedhelm E, Silberhorn E, Boger RH: Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects. Eur J Clin Invest 35: 622-626, 2005
28. Matsumoto Y, Ueda S, Yamagishi SI, Matsuguma K, Shibata R, Fukami K, Matsuoka H, Imaizumi T, Okuda S: Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease. J Am Soc Nephrol 18: 1525-1533, 2007
29. Verhagen AM, Attia DM, Koomans HA, Joles JA: Male gender increases sensitivity to proteinuria induced by mild NOS inhibition in rats: Role of sex hormones. Am J Physiol Renal Physiol 279: F664-17670, 2000
30. Ji H, Pesce C, Zheng W, Kim J, Zhang Y, Menini S, Haywood JR, Sandberg K: Sex differences in renal injury and nitric oxide production in renal wrap hypertension. Am J Physiol Heart Circ Physiol 288: H43-H47, 2005
31. Page A, Reich H, Zhou J, Lai V, Cattran DC, Scholey JW, Miller JA: Enclothelial nitric oxide synthase gene/gender interactions and the renal hemodynamic response to angiotensin II. J Am Soc Nephrol 16: 3053-3060, 2005
32. Gross ML, Adamczak M, Rabe T, Harbi NA, Krtil J, Koch A, Hamar P, Amann K, Ritz E: Beneficial effects of estrogens on indices of renal damage in uninephrectomized SHRsp rats. J Am Soc Nephrol 15: 348-358, 2004
33. Zhu W, Smart EJ: Caveolae, estrogen and nitric oxide. Trends Endocrinol Metab 14: 114-117, 2003
34. Baylis C: Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J Clin Invest 94: 1823-1829, 1994
35. Neugarten J, Ding Q, Friedman A, Lei J, Silbiger S: Sex hormones and renal nitric oxide synthases. J Am Soc Nephrol 8: 1240-1246, 1997
36. Stringer KD, Komers R, Osman SA, Oyama TT, Lindsley JN, Anderson S: Gender hormones and the progression of experimental polycystic kidney disease. Kidney Int 68: 1729-1739, 2005
37. Park KM, Kim JI, Ahn Y, Bonventre AJ, Bonventre JV: Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem 279: 52282-52292, 2004
38. Andreoli SP: Hormone replacement therapy in postmenopausal women with end-stage renal disease (1). Kidney Int 57: 341-342, 2000
39. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J Am Soc Nephrol 11: 319-329, 2000
40. Saitta A, Altavilla D, Cucinotta D, Morabito N, Frisina N, Corrado F, D'Anna R, Lasco A, Squadrito G, Gaudio A, Cancellieri F, Arcoraci V, Squadrito F: Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women. Arterioscler Thromb Vasc Biol 21: 1512-1519, 2001
41. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP: L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 90: 1248-1253, 1992
42. De Nicola L, Bellizzi V, Minutolo R, Andreucci M, Capuano A, Garibotto G, Corso G, Andreucci VE, Cianciaruso B: Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure. Kidney Int 56: 674-684, 1999
43. Schaufele TG, Schlaich MP, Delles C, Klingbeil AU, Fleischmann EH, Schmieder RE: Impaired basal NO activity in patients with glomerular disease and the influence of oxidative stress. Kidney Int 70: 1177-1181, 2006
44. Schneider MP, Klingbeil AU, Delles C, Schmidt BM, John S, Schmieder RE: Vitamin C augments the renal response to L-arginine in smokers. Nephrol Dial Transplant 18: 1512-1517, 2003
45. Suto T, Losonczy G, Qiu C, Hill C, Samsell L, Ruby J, Charon N, Venuto R, Baylis C: Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production. Kidney Int 48: 1272-1277, 1995
46. Klahr S, Morrissey J: L-arginine as a therapeutic tool in kidney disease. Semin Nephrol 24: 389-394, 2004
47. Podjarny E, Hasdan G, Bernheim J, Rashid G, Green J, Korzets Z, Bernheim J: Effect of chronic tetrahydrobiopterin supplementation on blood pressure and proteinuria in 5/6 nephrectomized rats. Nephrol Dial Transplant 19: 2223-2227, 2004